First Time Loading...

Horizon Therapeutics PLC
NASDAQ:HZNP

Watchlist Manager
Horizon Therapeutics PLC Logo
Horizon Therapeutics PLC
NASDAQ:HZNP
Watchlist
Price: 116.3 USD Market Closed
Updated: May 7, 2024

Horizon Therapeutics PLC
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Horizon Therapeutics PLC
Net Income (Common) Peer Comparison

Comparables:
ALKS
AMRN
PRTA
M
MURA

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Horizon Therapeutics PLC
NASDAQ:HZNP
Net Income (Common)
$438m
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Alkermes Plc
NASDAQ:ALKS
Net Income (Common)
$355.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
33%
Amarin Corporation PLC
NASDAQ:AMRN
Net Income (Common)
-$52.6m
CAGR 3-Years
N/A
CAGR 5-Years
15%
CAGR 10-Years
9%
Prothena Corporation PLC
NASDAQ:PRTA
Net Income (Common)
-$147m
CAGR 3-Years
-10%
CAGR 5-Years
1%
CAGR 10-Years
-14%
M
Mural Oncology PLC
NASDAQ:MURA
Net Income (Common)
-$207.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Horizon Therapeutics PLC's Net Income (Common)?
Net Income (Common)
438m USD

Based on the financial report for Jun 30, 2023, Horizon Therapeutics PLC's Net Income (Common) amounts to 438m USD.

What is Horizon Therapeutics PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
-5%

Over the last year, the Net Income (Common) growth was -43%. The average annual Net Income (Common) growth rates for Horizon Therapeutics PLC have been -5% over the past three years .